SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

CAW (Crow With Knife) is trending due to an exceptionally active and vocal community, frequently engaging in a spirited meme culture alongside $PMV. Supporters are consistently "spreading cawtism," emphasizing the crypto's organic, community-driven essence and bullish outlook for significant long-term growth. The narrative highlights CAW's potential to become a prominent multichain meme token.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PMV CRYPTO is gaining traction as its 'PumpMindVirus' meme culture continues to spread, championed by an actively engaged community focused on fun and consistent presence on the Solana ecosystem. Supporters emphasize its 'non-stop pressure' and long-term '2026 agenda,' frequently engaging in playful interactions with other trending tokens like $CAW, cementing its status as a robust meme play.

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is trending as the leading meme coin within the Injective ecosystem, with its community actively positioning it as a high-leverage play on Injective's strong fundamentals and ongoing technical developments. Enthusiasts are rallying around its robust, active community and high burned liquidity, anticipating significant upside as the broader Injective ecosystem continues to expand.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT is generating significant discussion following recent integrations with major trading platforms and its deep ties to the Coinbase Base ecosystem, positioning it as a key player in perpetual DEX and RWA trading. While many anticipate significant upside, citing its features and backing, a vocal segment of the community expresses strong concern over sustained price declines, labeling it a "rug pull" and questioning the commitment to its stated buyback initiatives.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as its highly active community relentlessly builds out a unique "permissionless brand" ecosystem, launching real-world products like Kendu Spice on Amazon and expanding into various initiatives. The engaged community expresses strong conviction in this multi-chain crypto project, available on ETH, SOL, and BASE, emphasizing continuous development and long-term growth.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is trending due to significant institutional backing from Nasdaq-listed Pineapple Financial, which committed to acquiring and staking INJ, alongside an SEC filing for a Staked INJ ETF. The community is buzzing with high expectations for its role as a leading Layer 1 blockchain focused on decentralized finance, real-world assets, and AI infrastructure. Discussions highlight INJ's deflationary tokenomics and upcoming MultiVM capabilities, driving conversation around its potential to bridge traditional and on-chain financial markets.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CRO is actively trending due to significant developments, including a strategic partnership with 21Shares US to explore potential ETF and private trust products, alongside Crypto.com's growing association with the Trump administration and Trump Media's notable CRO holdings. Community sentiment is mixed; while many investors anticipate substantial long-term growth driven by increased utility and regulated access, others voice frustration over the token's current price trajectory. Additionally, a pervasive discussion around the "Crow with Knife" ($CAW) meme coin aims to drive multi-chain volume to the Cronos ecosystem, further adding to the market chatter.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is trending amidst its latest earnings report, which presented mixed signals with a beat on estimates but cautious guidance due to ongoing U.S.-China export restrictions. While analysts are largely optimistic, raising price targets on strong AI-driven demand and long-term sector growth, the community is debating whether recent workforce reductions and geopolitical headwinds signal a healthy consolidation or a looming pullback. Investors are keenly watching its critical role in the semiconductor equipment industry's expansion and its strategic positioning in advanced manufacturing.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending due to its aggressive expansion into stock trading and prediction markets, alongside its Base app's growing capabilities for tokenization and leveraged trading. This strategic diversification is fueling community debate, with some viewing it as a necessary pivot beyond traditional crypto and others questioning its timing and competitive positioning against established platforms.

Aster is a next-generation decentralized perpetual exchange that combines non-custodial trading with advanced features like hidden orders and multi-chain support. The platform emerged from the merger of Astherus and APX Finance in late 2024, with APX token holders able to migrate their holdings to ASTER.  Aster addresses the gap between centralized and decentralized exchanges by enabling traders to maintain full control of their assets while accessing deep liquidity and CEX-grade trading tools. The platform supports trading of both cryptocurrency perpetuals and U.S. stocks with up to 100x leverage, all settled on-chain in crypto without requiring traditional financial infrastructure.  The platform offers two distinct trading modes to accommodate different user needs. Simple Mode provides one-click, MEV-resistant trading with up to 1001x leverage for beginners, while Pro Mode delivers a full order book with advanced features like automated grid trading and hidden orders that remain invisible until execution.   Aster operates across BNB Chain, Ethereum, Solana, and Arbitrum without requiring bridging, with liquidity pooled across markets to support large trades with minimal slippage. A distinctive feature allows users to deposit yield-generating assets like asBNB or USDF as collateral, earning passive returns while trading, maximizing capital efficiency compared to platforms where collateral sits idle.  Aster received backing from YZi Labs (formerly Binance Labs), which holds a minority stake through a private fund managing over $10 billion on behalf of early Binance executives. Changpeng Zhao, founder of Binance, serves in an advisory role and has personally invested over $2.5 million worth of ASTER tokens.   The ASTER token serves multiple functions including governance rights, staking rewards through liquidity provision, and earning incentives through the platform's points program for traders and liquidity providers.

ASTERION

ASTER is trending amid intense community discussion about its potential in the perpetual decentralized exchange (DEX) market, significantly amplified by a high-profile personal purchase. Traders are actively debating its trajectory against rivals like Hyperliquid, with conversations swirling around its roadmap, tokenomics, and market legitimacy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 52-Week High Following Analyst Upgrade

Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 52-Week High After Analyst Upgrade...

Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Up 8.9% Following Analyst Upgrade

Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Up 8.9% Following Analyst Upgrade...

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $140.00

Citizens Jmp increased their price target on shares of Mirum Pharmaceuticals from $95.00 to $140.00 and gave the company a "market outperform" rating in a report on Friday...

Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a subscription agreement with entities associated with TCGX, an institutional...

Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026?

Mirum's Livmarli sales surge 70% in the first nine months of 2025. Expanding approvals and commercialization are set to fuel revenue momentum into 2026.

Stifel Nicolaus Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price

Stifel Nicolaus upped their target price on shares of Mirum Pharmaceuticals from $92.00 to $98.00 and gave the company a "buy" rating in a research report on Tuesday...

Eventide Asset Management LLC Has $134.22 Million Holdings in Mirum Pharmaceuticals, Inc. $MIRM

Eventide Asset Management LLC raised its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 4.4% during the second quarter, according to its most recent filing with the Securities...

Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by BVF Inc. IL

BVF Inc. IL lessened its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 1.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional...

Boone Capital Management LLC Has $32.64 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRM

Boone Capital Management LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.3% during the second quarter, according to its most recent filing with the...

What is HC Wainwright's Forecast for MIRM FY2025 Earnings?

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Mirum Pharmaceuticals in a note issued to investors on Tuesday...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Current Price	$77.74
Prev Close	$70.28
Open	$70.76
Dividend Yield	0.00%
50-Day Moving Average	$70.48
Beta	0.75
Avg. Volume	606,806.05
PE Ratio	-90.21

52-Week High	$79.95
52-Week Low	$36.88
Market Capitalization	$3.63B
EPS (Annual)	-$1.85
Price to Book	13.66
Revenue Per Employee	$1.05M
Enterprise Value/EBITDA	N/A

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MIRM News

MIRMMirum Pharmaceuticals Inc